作者: Sheng-Mou Hsiao , Ho-Hsiung Lin
DOI: 10.1016/J.JFMA.2018.01.011
关键词: Overactive bladder syndrome 、 Medicine 、 Adverse effect 、 Urodynamic studies 、 Urine biomarkers 、 Urology 、 Urinary bladder 、 Vaginal estrogen 、 Medical treatment
摘要: The age-adjusted prevalence of overactive bladder syndrome (OAB) in Taiwan is approximately 16.9%. Currently, a variety treatments are available for female OAB. However, different have treatment-related effects that may lead to significant adverse and ineffective treatment. In this article, we reviewed the tools can be used evaluate efficacy OAB treatments, such as questionnaires, serum or urine biomarkers, diaries urodynamic studies. addition, medications treatment, antimuscarinics, beta-3 agonists, onabotulinumtoxinA intradetrusor injections, topical vaginal estrogen therapy instillation liposome-encapsulated onabotulinumtoxinA. We focused on their any effects. information review should useful guide treatment patients.